相似文献/References:
[1]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[2]赵倩 金学民.Avastin联合黄斑格栅样光凝治疗糖尿病黄斑水肿的临床研究[J].眼科新进展,2013,33(2):000.
[3]赵勇 张卯年 任兵.激素缓释系统治疗糖尿病黄斑水肿新进展[J].眼科新进展,2012,32(10):000.
[4]肖慧珍 彭绍民.紧密连接在视网膜病理生理中的作用[J].眼科新进展,2013,33(5):000.
[5]曹薇 崔红平 张美萍.23G微切口玻璃体切割手术治疗糖尿病视网膜病变[J].眼科新进展,2013,33(11):000.
[6]刘斌,杨玉霞,刘杏,等.玻璃体内注射Lucentis治疗糖尿病黄斑水肿[J].眼科新进展,2015,35(1):045.[doi:10.13389/j.cnki.rao.2015.0013]
LIU Bin,YANG Yu-Xia,LIU Xing,et al.Intravitreal injection of Lucentis for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(2):045.[doi:10.13389/j.cnki.rao.2015.0013]
[7]王博,吴京,马明,等. 玻璃体内注射雷珠单抗与曲安奈德治疗糖尿病黄斑水肿的疗效对比分析[J].眼科新进展,2015,35(3):246.[doi:10.13389/j.cnki.rao.2015.0066]
WANG Bo,WU Jing,MA Ming,et al. Clinictid effect comparison of intravitreal lucentis and triamcinolone acetonide for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(2):246.[doi:10.13389/j.cnki.rao.2015.0066]
[8]徐浩,白宁艳,吕鹏,等. 雷珠单抗玻璃体内注射与黄斑部格栅样光凝联合治疗糖尿病性黄斑水肿的疗效观察[J].眼科新进展,2015,35(8):781.[doi:10.13389/j.cnki.rao.2015.0215]
XU Hao,BAI Ning-Yan,LV Peng,et al. Intravitreous injection of ranibizumab combined with macular grid photocoagulation for diabetic macular edema[J].Recent Advances in Ophthalmology,2015,35(2):781.[doi:10.13389/j.cnki.rao.2015.0215]
[9]董秀清,冯松福,柯晓云.应用光学相干断层扫描量化评估糖尿病黄斑水肿的临床研究[J].眼科新进展,2017,37(2):133.[doi:10.13389/j.cnki.rao.2017.0035]
DONG Xiu-Qing,FENG Song-Fu,KE Xiao-Yun.Evaluating diabetic macular edema quantificationally by optical coherence tomography[J].Recent Advances in Ophthalmology,2017,37(2):133.[doi:10.13389/j.cnki.rao.2017.0035]
[10]李疏凤,王帅,李婷婷,等.多重酪氨酸激酶受体抑制剂decorin对高糖低氧条件下血-视网膜内屏障的保护作用及机制研究[J].眼科新进展,2017,37(6):501.[doi:10.13389/j.cnki.rao.2017.0127]
LI Shu-Feng,WANG Shuai,LI Ting-Ting,et al.Protective effects of decorin on blood-retinal barrier function under high-glucose plus hypoxia conditions[J].Recent Advances in Ophthalmology,2017,37(2):501.[doi:10.13389/j.cnki.rao.2017.0127]